← FDA DRUG APPROVALS

FDA ANDA · ANDA077763

CLOBETASOL PROPIONATE

Sponsor: PADAGIS ISRAEL

APPLICATION
ANDA077763
TYPE
ANDA
ORIGINAL APPROVAL
2008-03-10
LATEST ACTION
2019-11-14
ROUTE
TOPICAL
DOSAGE FORM
AEROSOL, FOAM
MARKETING STATUS
Prescription

Products

CLOBETASOL PROPIONATEPrescription
CLOBETASOL PROPIONATE 0.05% · AEROSOL, FOAM · TOPICAL

Approval history

2019-11-14Labeling · Supplement 13 · standardAP
2019-11-14Labeling · Supplement 11 · standardAP
2008-03-10OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →